Finance

Lists
Why is 605507 down 2.22%?
Dive Deeper
605507:SHA
Guobang Pharma Ltd
CNÂ¥15.84
-2.22%
(-0.36) 1D
Oct 16, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 605507...
Open
CNÂ¥16.29
High
CNÂ¥16.54
Low
CNÂ¥15.71
Mkt. cap
12.67B
Avg. vol.
8.69M
Volume
6.50M
Dividend
2.71%
Quarterly dividend
CNÂ¥0.11
Ex-dividend date
May 29, 2026
P/E ratio
17.41
52-wk high
CNÂ¥21.41
52-wk low
CNÂ¥14.34
EPS
CNÂ¥0.91
No. of employees
4K
Open
CNÂ¥16.29
High
CNÂ¥16.54
Low
CNÂ¥15.71
Mkt. cap
12.67B
Avg. vol.
8.69M
Volume
6.50M
Dividend
2.71%
Quarterly dividend
CNÂ¥0.11
Ex-dividend date
May 29, 2026
P/E ratio
17.41
52-wk high
CNÂ¥21.41
52-wk low
CNÂ¥14.34
EPS
CNÂ¥0.91
No. of employees
4K
News stories
From web sources and news partners
About Guobang Pharma Ltd
CEO-
Employees4.25K
FoundedMar 29, 1996
Headquarters-
SectorPharmaceutical industry
Websitegbgcn.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.44B
1.54B
1.52B
1.62B
Cost of goods sold
1.04B
1.22B
1.17B
1.23B
Cost of revenue
1.04B
1.22B
1.17B
1.23B
Research and development expenses
56.01M
56.39M
29.72M
68.59M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
95.62M
91.84M
97.88M
102.20M
Operating expense
147.58M
163.74M
144.00M
181.88M
Total operating expenses
1.19B
1.38B
1.31B
1.42B
Operating income
251.14M
162.24M
206.77M
205.09M
Other non operating income
-6.09M
4.26M
-17.56M
15.56M
EBT including unusual items
253.57M
176.38M
187.17M
200.66M
EBT excluding unusual items
249.16M
157.04M
186.75M
187.38M
Income tax expense
39.67M
26.70M
27.04M
19.47M
Effective tax rate
15.65%
15.14%
14.45%
9.70%
Other operating expenses
-3.71M
17.40M
6.70M
16.35M
Net income
214.67M
150.58M
160.63M
180.72M
Net profit margin
14.87%
9.77%
10.56%
11.14%
Earnings per share
-
-
-
-
Interest and investment income
12.79M
6.57M
6.74M
4.95M
Interest expense
-5.20M
-6.86M
-9.19M
-1.98M
Net interest expenses
7.59M
-292.84K
-2.45M
2.97M
Depreciation and amortization charges
-
-
-
-
EBITDA
359.34M
281.48M
326.01M
328.14M
Gain or loss from assets sale
-453.56K
-24.81M
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps